Swedbank Ab Vertex Pharmaceuticals Inc Transaction History

Swedbank Ab

$95.2 Billion
Q3 2025

A detailed history of Swedbank Ab transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Swedbank Ab holds 254,096 shares of VRTX stock, worth $110 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

254,096

Previous 254,347 0.1%

Holding current value

$110 Million

Previous $113 Million 12.12%

% of portfolio

0.1%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$366.54 - $479.53 $92,001 - $120,362	-251 Reduced 0.1%	254,096 $99.5 Million
Q2 2025 Jul 10, 2025	SELL	$421.16 - $509.5 $15 Million - $18.2 Million	-35,727 Reduced 12.32%	254,347 $113 Million
Q1 2025 Jun 23, 2025	SELL	$402.49 - $513.76 $67 Million - $85.5 Million	-166,513 Reduced 36.47%	290,074 $141 Million
Q4 2024 Jan 23, 2025	BUY	$396.64 - $516.74 $181 Million - $236 Million	456,587 New	456,587 $184 Million
Q3 2024 Oct 15, 2024	SELL	$460.0 - $505.78 $40.3 Million - $44.4 Million	-87,699 Reduced 13.16%	578,513 $269 Million

Q2 2024 Jul 18, 2024	BUY	$392.81 - $485.53 $262 Million - $323 Million	666,212 New	666,212 $312 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $270 Million - $296 Million	663,422 New	663,422 $277 Million
Q4 2023 Dec 09, 2024	SELL	$343.0 - $410.68 $3.16 Million - $3.79 Million	-9,223 Reduced 1.37%	664,034 $270 Million
Q3 2023 Dec 09, 2024	BUY	$338.18 - $362.46 $19.6 Million - $21 Million	57,839 Added 9.4%	673,257 $234 Million
Q2 2023 Dec 09, 2024	SELL	$314.42 - $351.91 $4.93 Million - $5.52 Million	-15,682 Reduced 2.48%	615,418 $217 Million
Q1 2023 Dec 09, 2024	SELL	$283.23 - $323.1 $1.8 Million - $2.05 Million	-6,346 Reduced 1.0%	631,100 $199 Million
Q4 2022 Dec 09, 2024	BUY	$285.76 - $321.48 $1.41 Million - $1.59 Million	4,932 Added 0.78%	637,446 $184 Million
Q3 2022 Dec 09, 2024	SELL	$273.83 - $305.53 $13.5 Million - $15.1 Million	-49,384 Reduced 7.24%	632,514 $183 Million
Q2 2022 Dec 09, 2024	SELL	$234.96 - $292.55 $1.6 Million - $1.99 Million	-6,790 Reduced 0.99%	681,898 $192 Million
Q1 2022 Dec 09, 2024	BUY	$221.42 - $260.97 $5.43 Million - $6.4 Million	24,532 Added 3.69%	688,688 $180 Million
Q4 2021 Dec 09, 2024	BUY	$177.01 - $223.45 $1.59 Million - $2 Million	8,960 Added 1.37%	664,156 $146 Million
Q3 2021 Dec 09, 2024	BUY	$181.39 - $202.99 $7.87 Million - $8.81 Million	43,410 Added 7.1%	655,196 $119 Million
Q2 2021 Dec 09, 2024	BUY	$187.49 - $221.1 $9.91 Million - $11.7 Million	52,853 Added 9.46%	611,786 $123 Million
Q1 2021 Dec 09, 2024	BUY	$207.02 - $241.31 $116 Million - $135 Million	558,933 New	558,933 $120 Million

Others Institutions Holding VRTX

# of Institutions

1,786

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account